Recent reports in Science and Medicine for May 2004

Some of these links are very transient and may expire within days of posting. Some may require prior registration. Check-in and view frequently to avoid missing great news items. I welcome any suggested articles. (email link). "§" indicates a recommended article.

May 28

Weekend Reading - Basic Science and general interest articles

  1. § Arnold Beckman dies at 104. Inventor of the pH meter and DU spectrophotometer amassed a fortune and pumped millions into basic research. The son of a blacksmith, Beckman created instruments that are now employed in virtually every laboratory across the globe, then used his fortune to up the pace of basic research. [The Scientist report]
  2. § Dogs to Help in Gene Hunts. Science 20 May 2004
  3. Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. PNAS published May 21, 2004, 10.1073/pnas. {The Scientist report: Plasmid-encoding toxin found in B. cereus taken from apparent inhalation anthrax case]
  4. Tigecycline, a first-in-class expanded broad spectrum antibiotic, produced a 74 percent cure rate in hospitalized patients with possibly life-threatening, complicated skin and skin structure infections. Tigecycline is currently in Phase 3 clinical trials and was developed by Wyeth Pharmaceuticals.Eurekalert
  5. Combination therapy dramatically improves function after spinal cord injury in rats [Eurekalert report from Nature Medicine
  6. PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nature Medicine online: 23 May 2004 | doi:10.1038/nm1055
  7. CDER 2003 Report to the Nation: Improving Public Health Through Human Drugs (pdf or slides)

May 27

  1. pRb2/p130, VEGF, p27(KIP1) and PCNA expression in hepatocellular carcinoma: their clinical significance. Clinical Cancer Research [Eurekalert: Expression of Rb2/p130 and VEGF could serve as potential liver cancer prognosticators]
  2. Commentaries: Anti–ß1-adrenergic receptor antibodies and heart failure: causation, not just correlation.J. Clin. Invest. 2004 113: 1379-1382.
  3. Psychological factors may be root of back pain, say Stanford researchers [Eurekalert review from the May 15 issue of Spine -no access]

May 26

  1. Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer. J Natl Cancer Inst 2004; 96: 739-749.
  2. § Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function. Arch Neurol. 2004;61:661-666.
  3. The Lancet Volume 363, Number 9422     22 May 2004

May 25

  1. New England Journal of Medicine May 20, 2004 Volume 350 Number 21 Summaries
  2. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004 79: 437-443. {Iron supplements help only certain women who are not anemic. News report]
  3. § Clozapine in drug induced psychosis in Parkinson’s disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 2004; 75: 689-695.
  4. Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice: A Renoprotective Combination? Ye, et al. Hypertension 2004 43: 1120-1125, doi:10.1161/{Eurekalert]

May 24

  1. Human bone marrow megakaryocytes and platelets express PPAR and PPAR agonists blunt platelet release of CD40 ligand and thromboxanes. Blood First Edition Paper, prepublished online May 6, 2004 ['Good guy' blood cells are now suspects in heart disease, diabetes: Eurekalert]
  2. § CDER News May 19, 2004
    • FDA approvals: Avelox (moxifloxacin) for community-acquired pneumonia; Taxotere (docetaxel) for advanced metastatic prostate cancer; Gemzar for metastatic breast cancer; Vidaza for myelodysplastic syndrome subtypes; Orange Book: Cumulative Supplement No 4 (updated)
  3. This Week in JAMA. 2004;291:2285.

May 21

Weekend Reading - Basic Science and general interest articles

  1. Recombination of Human Mitochondrial DNA. Kraytsberg, et al. Science, Vol 304, Issue 5673, 981
  2. Canadian Medical Association develops publication informing doctors about health information technology in Canada [ Future Practice 2004]
  3. § Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. PNAS published May 11, 2004, 10.1073/pnas.(New molecule may be basis for drugs that battle overeating and drug dependency)
  4. New compound may act to keep thyroid activity in check [Eurekalert review from online edition of the journal Nature Medicine.3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone]
  5. Rand study shows people at risk of receiving poor health care in all parts of the United States; published in Health Affairs.
  6. The Enormity of Obesity. Researchers continue to struggle to find a chemical cure for the seriously overweight New Scientist Volume 18 | Issue 10 | 20 | May. 24, 2004
  7. FDA News: FDA Approves Vidaza (azacitidine) for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.

May 20

  1. The Lancet Volume 363, Number 9421 - 15 May 2004
  2. New Approaches to Better Manage Fatigue and Sleepiness Associated With Common Medical Conditions [Medscape review]
  3. § MEDWATCH Report: Desyrel (trazodone hydrochloride) Revisions to the CLINICAL PHARMACOLOGY and PRECAUTIONS. Potential for drug interactions:trazodone and CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir.
  4. Hospital gowns' benefits outweigh costs in intensive care unit. [Eurekalert report from Infection Control and Hospital Epidemiology.]
  5. Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis. Am. J. Respir. Crit. Care Med. 2004; 169: 1103-1109.

May 19

  1. Annals of Internal Medicine 18 May 2004 Volume 140 Issue 10
  2. Should -blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. JACI 2004: 113 (5)
  3. § Guidelines for Empiric Antimicrobial Prescribing in Community-Acquired Pneumonia* File, et al. Chest. 2004;125:1888-1901
  4. Empiric Therapy of Community-Acquired Pneumonia* Guidelines for the Perplexed? Cunha. Chest. 2004;125:1913-1919.
  5. § Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Turkington, et al. Thorax 2004; 59: 367-371.[Medscape : Sleep Apnea Increases Morbidity, Mortality After Stroke]
  6. § Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Gossec, et al. Ann Rheum Dis 2004; 63: 675-680.[Medscape review: Predictors of Remission in Early Rheumatoid Arthritis Identified]

May 18

  1. New England Journal of Medicine Volume 350 May 13, 2004 Number 20  Summaries
  2. Mayo Clinic Proceedings May 2004  Volume 79  Number 5

May 17

  1. § FDA News:  NMEs Approved in Calendar Year 2004 to date.
  2. FDA Drug and Device Approvals: May 13, 2004 [Medscape report] Yael Waknine (Enjuvia), Hyaluronidase Injectable (Vitrase) Generic Metformin HCl Extended-Release Tablets (Fortamet), LidoSite, German approval: Ezetimibe/Simvastatin Combination (Inegy). [Medscape report]
  3. This Week in JAMA 2004;291:2169.
  4. BMJ 15 May 2004 (Vol 328, No 7449)

May 14

Weekend Reading - Basic Science and general interest articles

  1. § Spina Bifida and Anencephaly Before and After Folic Acid Mandate --- United States, 1995--1996 and 1999--2000 Mor Mortal Wkly Rep CDC Surveill Summ 2004;53:362-365. [Medscape: US Folate Fortification Strategy Only Partially Successful in Reducing Birth Defects]
  2. § Obesity reversed in mice by destroying blood vessels that service fat cells [Eurekalert and New Scientist reports from Nature Medicine]
  3. Uncertainty in clinical tests raises health care costs [Eurekalert report and link to NIST report]
  4. GlyR 3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization. Harvey, et al. Science, Vol 304, Issue 5672, 884-887.[Eurekalert and Science NOW reviews]
  5. § Allyl isothiocyanate causes mitotic block, loss of cell adhesion and disrupted cytoskeletal structure in HT29 cells. Carcinogenesis Advance Access DOI: 10.1093. [The bitter truth – why greens are good for us.Times]
  6. New study: Small, frequent doses of caffeine best strategy for staying awake [Eurekalert report from May issue of the journal Sleep]

May 13

  1. § Triglycerides Induce Leptin Resistance at the Blood-Brain Barrier. Diabetes 2004 53: 1253-1260. [NewScientist review]
  2. Sunlight and the 10-Year Incidence of Age-Related Maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol. 2004;122:750-757.
  3. Associations of Mortality With Ocular Disorders and an Intervention of High-Dose Antioxidants and Zinc in the Age-Related Eye Disease Study. AREDS Research Group Arch Ophthalmol. 2004;122:716-726.
  4. § Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women. Circulation 2004 109: 2191 - 2196
  5. Repairing the foundation: the future of primary care. CMAJ 2004 170: 1509; doi:
  6. In This Issue of Archives of Internal Medicine 2004;164:929.
  7. § RAPID PUBLICATION: Low-Dose Repeated Caffeine Administration for Circadian-Phase-Dependent Performance Degradation During Extended Wakefulness. Wyatt; et al.SLEEP Volume 27/ Issue 3, May 1, 2004 [news release]
  8. Food displays, food colors affect how much people eat [Eurekalert report from the Journal of Consumer Research.]
  9. Living wills don't work. [Eurekalert report from the bioethics journal the Hastings Center Report]
  10. Rationing Access to Care to the Medically Uninsured: The Role of Bureaucratic Front-Line Discretion at Large Healthcare Institutions [Eurekalert report from Medical Care]

May 12

  1. BMJ 8 May 2004 (Vol 328, No 7448)
  2. The Lancet Volume 363, Number 9420     08 May 2004
  3. American Academy of Nuerology Practice Guidelines: Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy (.pdf) [Eurekalert review]
  4. § Mycoplasma pneumoniae and Asthma in Children Clinical Infectious Diseases 2004;38:1341-1346 [Medscape review]
  5. What Residents Don't Know about Physician-Pharmaceutical Industry Interactions. Acad Med 2004 79: 432-437.[Medscape comments]

May 11

  1. New England Journal of Medicine Volume 350 May 6, 2004
  2. CDC Releases New Guidelines on Influenza Immunization [Medscape report]
  3. § Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: Results of a randomized, controlled trial. Arthritis & Rheumatism 2004; 50: 1066 - 1076.
  4. § Metabolic Cardiovascular Disease Risk Factors in Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab 2004 89: 2114-2118
  5. SPECT imaging shows promise for accurate, early diagnosis of Alzheimer's [Eurekalert report from J Nucl Med ]
  6. § Diagnosis and Localization of Pheochromocytoma. Hypertension. 2004;43:907.
  7. Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions. Stroke. 2004;35:1057.
  8. FDA Drug and Device Approvals: May 6, 2004 [Medscape Summary]

May 10

  1. JAMA. 2004;291:2049
  2. Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial Infarction. Circulation 2004: published online before print April 26, 2004
  3. § Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features. Circulation 2004: published online before print April 26, 2004
  4. § Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia. J Natl Cancer Inst 2004; 96: 673-682 and EDITORIAL: MCL-1 Promoter Insertions Dial-Up Aggressiveness of Chronic Leukemia. J Natl Cancer Inst 2004; 96: 642-643.]
  5. § Skin Cancers and Non-Hodgkin Lymphoma Among Users of Systemic Glucocorticoids: A Population-Based Cohort Study. J Natl Cancer Inst 2004; 96: 709-711.
  6. Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation? Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:628.

May 7

Weekend Reading - Basic Science and general interest articles

  1. The cleft lip and palate defects in Dancer mutant mice result from gain of function of the Tbx10 gene PNAS published April 26, 2004,
  2. Alzheimer's gene therapy trial shows early promise [New Scientist report]
  3. More than just filling space, the extracellular matrix affects human health [New Scientist article]
  4. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 2004 113: 1277-1287.
  5. § Deletion of vanilloid receptor 1_expressing primary afferent neurons for pain control. J. Clin. Invest. 2004 113: 1344-1352.[Science Daily : Studies Show Promise Treating Severe Chronic Pain]

May 6

  1. Annals of Internal Medicine 4 May 2004 Volume140 Issue 9 (Contents)
  2. Researchers identify novel method of distinguishing Alzheimer’s disease from other types of dementia [Eurekalert report from Journal of Nuclear Medicine]
  3. The Effects of Sleep Loss and Fatigue on Resident-Physicians: A Multi-Institutional, Mixed-Method Study. Acad Med 2004 79: 394-406. [Eurekalert]
  4. FDA News: Agency Guidances Promote Comprehensive Efforts to Minimize Risks While Preserving the Benefits of Medical Products
  5. FDA Approves Vitrase (Hyaluronidase for Injection)
  6. FDA Medwatch: Oxandrin (oxandrolone, USP) Savient Pharmaceuticals, Inc. notified healthcare professionals of an important drug interaction between Oxandrin, warfarin.
  7. Anemia Linked to Disability and Poor Physical Performance in Elderly. [Medscape report from J Am Geriatr Soc 2004;52:1-6.]
  8. Alcohol Consumption and Risk of Stroke Among Middle-Aged Men: The JPHC Study Cohort I. Stroke 2004 35: 1124 - 1129 [Medscape: Light Alcohol Consumption Does Not Increase Stroke Risk]
  9. Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial . Stroke 2004 35: e106 - e108
  10. § Agreement Between Ambulance Paramedic- and Physician-Recorded Neurological Signs With Face Arm Speech Test (FAST) in Acute Stroke Patients. Stroke published online April 29, 2004

May 5

  1. § How Does The Quality Of Care Compare In Five Countries? Health Affairs 2004 Vol 23, Issue 3, 89-99 . [U.S. health care not always best in world, study says. USA Today, ABC News, JHB report]
  2. U.S. Health Care Spending In An International Context. Health Affairs, Vol 23, Issue 3, 10-25
  3. The Association of Caffeinated Beverages With Blood Pressure in Adolescents. Arch Pediatr Adolesc Med. 2004;158:473-477.
  4. New England Journal of Medicine Early Release: Posted April 29, 2004
  5. The Lancet Volume 363, Number 9419     01 May 2004
  6. BMJ 1 May 2004 (Vol 328, No 7447)
  7. Patients Receive Fewer Services From for-Profit Hospice Providers [Medscape report from the May issue of Med Care. 2004;42:432-438.]
  8. [Eurekalert report: in the May 2004 Annals of Emergency Medicine. Prudent-layperson laws help get insurance coverage for emergency room visits
  9. FDA Safety Labeling Changes: April 29, 2004 [Medscape reveiw]
  10. Fluoroquinolone-Resistant Gonorrhea Rates on the Rise in the US [Medscape report from Mor Mortal Wkly Rep CDC Surveill Summ 2004;53:335-338.]
  11. Food habits are related to glycemic control among people with type 2 diabetes mellitus. Savoca, et al. J Am Dietitic Assc. 2004 [Eurekalert discussion]
  12. Outcomes following childhood head injury: a population study.J Neurol Neurosurg Psychiatry 2004; 75: 737-742.

May 4

  1. Shortage of Specialists in Geriatric Care at Crisis Level: Report [Medscape report from the American Geriatrics Society]
  2. New England Journal of Medicine Volume 350 April 29, 2004 Number 18  Article Summaries
  3. FDA: § A Message About HIPAA Compliance for Reporters to FDA MedWatch [You can continue to make adverse event reports under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule.]
  4. FDA Talk Paper: FDA Updates Zelnorm Labeling with New Risk Information
  5. FDA Approves Apidra (Insulin glulisine), Nasacort HFA, Ziagen, New Zantac Dose, New Proscar Regimen [Medscape report]
  6. FDA Talk Paper *** CLARIFICATION *** FDA Approves Apokyn for the Acute Treatment of Episodes of Immobility in Parkinson’s Patients
  7. NTP-CERHR (Center for the Evaluation of Risks to Human Reproduction) Expert anel Report on the Reproductive and Developmental Toxicity of Fluoxitine (pdf file)
  8. Represcription of penicillin after allergic-like events. JACI 2004; 113:764.
  9. Cranberry Juice and Urinary Tract Infectio. CID 2004; 189: 1413. [Eurekalert report]
  10. Trends in Antimicrobial Drug Development: Implications for the Future. CID 2004;38:1279-1286
  11. Community-Onset Methicillin-Resistant Staphylococcus aureus Associated with Antibiotic Use and the Cytotoxin Panton-Valentine Leukocidin during a Furunculosis Outbreak in Rural Alaska. JID 2004;189:1565-1573. [Eurekalert report]
  12. HRT gets another chance. Privately funded 5-year US trial will test effects of early estrogen [The Scientist report]
  13. Triglycerides Induce Leptin Resistance at the Blood-Brain Barrier. Diabetes 2004 53: 1253-1260.[Science Daily report: Winning The Battle Of The Bulge: We're A Scrimmage Closer To Victory]

May 3

  1. This Week in JAMA. 2004;291:1931.
  2. Circulation 109, Issue 16; April 27, 2004